Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
869.01B
Market cap869.01B
Price-Earnings ratio
40.08
Price-Earnings ratio40.08
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.96M
Average volume2.96M
High today
$924.14
High today$924.14
Low today
$890.00
Low today$890.00
Open price
$893.50
Open price$893.50
Volume
3.46M
Volume3.46M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 869.01B, Eli Lilly(LLY) trades at $923.70. The stock has a price-to-earnings ratio of 40.08 and currently yields dividends of 67.7%.

During the trading session on 2026-04-01, Eli Lilly(LLY) shares reached a daily high of $924.14 and a low of $890.00. At a current price of $923.70, the stock is +3.8% higher than the low and still -0.0% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 3.46M, versus its average volume of 2.96M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

Simply Wall St 1h
Eli Lilly’s Centessa Deal Puts Sleep Disorders In Investor Focus

Eli Lilly (NYSE:LLY) agreed to acquire Centessa Pharmaceuticals in a deal valued at up to US$7.8b. The transaction would expand Lilly’s neuroscience portfolio...

Eli Lilly’s Centessa Deal Puts Sleep Disorders In Investor Focus
TipRanks 6h
Lilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 9h
Why Centessa Stock Soared Today

Key Points Centessa possesses a promising sleep medicine pipeline. The clinical-stage company's experimental therapies have blockbuster potential. 10 stocks...

Why Centessa Stock Soared Today

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

TipRanks 16h
Lonza Strengthens Board With Nomination of Former Eli Lilly Executive Stephen Fry

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 18h
Alkermes jumps after Eli Lilly acquires peer Centessa

Shares of Alkermes (ALKS) ALKS) are moving higher after Eli Lilly (LLY) reached an agreement to acquire Centessa (CNTA) for up to $7.8B. Alkermes, like Centessa...

Benzinga 20h
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

Acquisition Expands Eli Lilly’s Neuroscience Portfolio The acquisition aims to enhance Lilly’s neuroscience portfolio, particularly in sleep medicine, as it se...

Eli Lilly Expands Into Sleep Medicine With Centessa Buyout
CNBC 20h
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Eli Lilly has agreed to pay...

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Nasdaq 20h
Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company

(RTTNews) - Shares of Centessa Pharmaceuticals plc (CNTA) are climbing about 45 percent on Tuesday morning trading after Eli Lilly and Company announced an agre...

Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company
Investor's Business Daily 21h
Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket

Technology Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket Licensing Eli Lilly (LLY) said Tuesday it would buy sleep-wake dis...

Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket
MarketWatch 22h
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Eli Lilly is spending up to $7.8 billion to buy Centessa, which is working on treatments for sleep-wake disorders. Eli Lilly has made yet another deal, this ti...

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.